Hyperphosphatemia is a predictable consequence of chronic renal failure and is present in
most patients on dialysis. Traditionally, the risk associated with elevated serum phosphorus …

Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure.
Background Parathyroid hormone and vitamin D have been shown to influence cardiac and …

Introduction: Chronic kidney disease as a public health problem. Chronic kidney disease is
a worldwide public health problem. In the United States, there is a rising incidence and …

Background Cardiovascular disease is common in older adults with end-stage renal disease
who are undergoing regular dialysis, but little is known about the prevalence and extent of …

Elevated serum phosphorus is a predictable accompaniment of end-stage renal disease
(ESRD) in the absence of dietary phosphate restriction or supplemental phosphate binders …

Background Treatment of secondary hyperparathyroidism with vitamin D and calcium in
patients receiving dialysis is often complicated by hypercalcemia and hyperphosphatemia …

Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and
Practice Patterns Study. Background Altered mineral metabolism contributes to bone …

Background: Mineral metabolism has emerged as an important predictor of morbidity and
mortality in dialysis patients, independent of bone and muscle concerns. Several expert …

Overcome the toughest clinical challenges in nephrology with the new 9th edition of
Brenner/Rector's The Kidney! A brand-new editorial team of Drs. Maarten W. Taal, Glenn M …

Elevated serum phosphorus is a major, preventable etiologic factor associated with the
increased cardiovascular morbidity and mortality of dialysis patients. An important …